ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
While most advanced prostate cancer is incurable, treatments can slow or shrink the cancer, reduce symptoms and extend a person’s life.
Preterm birth is the biggest cause of infant mortality and morbidity in the UK.1 Evidence has shown that optimal cord management (OCM), defined here as…
In the post-election whirlwind and as the holidays approach, those in health care can find strength in gratitude—for evidence-based policies like ACP’s, grounding professional values,…
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Women and girls have experienced some of the most brutal consequences of Sudan’s conflict. Eatizaz Yousif explains the role of the IRC in delivering essential…
Vanzacaftor/tezacaftor/deutivacaftor (Alyftek) also received approval for the treatment of cystic fibrosis in people 6 years and older who have at least 1 F508del mutation.
Compounding pharmacies have a 60- to 90-day grace period to complete production as it continues to monitor supply and demand.
This could be attributed to improved diet and health awareness.
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…